A bibliometric analysis of literatures on uterine leiomyosarcoma in the last 20 years.

Jinhua Huang, Yu Chen, Ziyin Li, Mimi Chen, Dingwen Huang, Peixin Zhu, Xintong Han, Yi Zheng, Xiaochun Chen, Zhiying Yu
Author Information
  1. Jinhua Huang: Department of Gynecology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.
  2. Yu Chen: Department of Gynecology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.
  3. Ziyin Li: Department of Gynecology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.
  4. Mimi Chen: Department of Gynecology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.
  5. Dingwen Huang: Department of Gynecology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.
  6. Peixin Zhu: Department of Gynecology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.
  7. Xintong Han: Department of Gynecology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.
  8. Yi Zheng: Department of Gynecology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.
  9. Xiaochun Chen: Department of Gynecology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.
  10. Zhiying Yu: Department of Gynecology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.

Abstract

Background: Uterine leiomyosarcoma(uLMS) is a rare malignant tumor with low clinical specificity and poor prognosis.There are many studies related to uLMS, however, there is still a lack of metrological analyses with generalization. This study provides a bibliometric study of uLMS.
Methods and materials: We chose the Web of Science (WoS) as our main database due to its extensive interdisciplinary coverage. We specifically focused on the literature from the last 20 years to ensure relevance and practicality. By utilizing the WOS core dataset and leveraging the R package "bibliometric version 4.1.0" and Citespace, we performed a comprehensive bibliometric analysis. This allowed us to pinpoint research hotspots and create visual representations, resulting in the retrieval of 2489 pertinent articles.
Results: This literature review covers 2489 articles on uterine leiomyosarcoma (uLMS) from the past 20 years. Key findings include an average annual publication rate of 8.75, with a 6.07% yearly growth rate and an average citation count of 17.22. Core+Zone 2 sources contributed 1079 articles and 207 reviews, displaying a 4.98% annual growth rate. The analysis identified top journals, influential authors, and core sources, such as the prevalence of publications from the United States and the dominance of and . Bradford's Law and Lotka's Law highlighted core sources and author productivity, respectively. Thematic mapping and factorial analysis revealed research clusters, including etiology, diagnosis, treatment advancements, and surgical approaches, with prominent themes such as gemcitabine and docetaxel. Overall, this comprehensive analysis provides insights into uLMS literature trends and influential factors.
Conclusion: This thorough bibliometric analysis, in its whole, illuminates the field's guiding principles while also revealing the subtle patterns within the uLMS literature. The knowledge gained here contributes to the current discussion in uLMS and related scientific fields and provides a solid basis for future research paths.

Keywords

References

  1. Methods Mol Biol. 2019;1897:289-298 [PMID: 30539453]
  2. Bull Cancer. 2023 Apr;110(4):440-449 [PMID: 36863922]
  3. J Neurosurg. 2016 Feb;124(2):569-79 [PMID: 26339849]
  4. J Med Libr Assoc. 2015 Oct;103(4):217-8 [PMID: 26512226]
  5. J Gynecol Oncol. 2018 May;29(3):e30 [PMID: 29533018]
  6. Heliyon. 2022 Sep 25;8(9):e10757 [PMID: 36185135]
  7. Am J Obstet Gynecol. 2015 Jan;212(1):18-23 [PMID: 25072737]
  8. J Minim Invasive Gynecol. 2014 Jul-Aug;21(4):517-30 [PMID: 24865630]
  9. Lancet Oncol. 2015 Nov;16(15):1454-1456 [PMID: 26545835]
  10. Gynecol Oncol. 2010 Jan;116(1):131-9 [PMID: 19853898]
  11. Surg Oncol. 2011 Dec;20(4):e127-31 [PMID: 21616660]
  12. Am J Obstet Gynecol. 2014 Apr;210(4):368.e1-368.e8 [PMID: 24368137]
  13. Rare Tumors. 2013 Sep 04;5(3):e42 [PMID: 24179654]
  14. Gynecol Oncol. 2018 Dec;151(3):562-572 [PMID: 30244960]
  15. Med Sci Monit. 2020 May 19;26:e923749 [PMID: 32425177]
  16. Med Sci Monit. 2020 Apr 09;26:e922739 [PMID: 32270788]
  17. Clin Pathol. 2022 Jun 27;15:2632010X221105224 [PMID: 35782597]
  18. Future Oncol. 2020 Apr;16(10):573-584 [PMID: 32141309]
  19. Prz Menopauzalny. 2017 Dec;16(4):113-117 [PMID: 29483851]
  20. Clin Pract. 2021 Nov 22;11(4):878-900 [PMID: 34842646]
  21. Cancer Sci. 2018 Jun;109(6):1743-1752 [PMID: 29660202]
  22. Pathol Int. 2010 Jul;60(7):506-9 [PMID: 20594271]
  23. Obstet Gynecol. 2021 Mar 1;137(3):e63-e74 [PMID: 33595252]
  24. J Magn Reson Imaging. 2016 Feb;43(2):333-42 [PMID: 26383110]
  25. Obstet Gynecol. 2003 May;101(5 Pt 2):1130-2 [PMID: 12738126]
  26. Arch Gynecol Obstet. 2023 Feb;307(2):379-386 [PMID: 35344084]
  27. Front Oncol. 2021 Jun 11;11:687899 [PMID: 34178683]
  28. PLoS Genet. 2016 Feb 18;12(2):e1005850 [PMID: 26891131]
  29. Front Med (Lausanne). 2023 Jun 07;10:1158815 [PMID: 37351071]
  30. Gynecol Oncol. 2017 Apr;145(1):208-216 [PMID: 28209496]
  31. Diagn Interv Imaging. 2019 Oct;100(10):619-634 [PMID: 31427216]
  32. J Clin Endocrinol Metab. 2013 Mar;98(3):921-34 [PMID: 23393173]
  33. Am J Surg Pathol. 2017 Jan;41(1):12-24 [PMID: 27631520]
  34. Gynecol Endocrinol. 2018 Mar;34(3):192-194 [PMID: 28933575]
  35. Gynecol Oncol Rep. 2022 Jul 14;42:101044 [PMID: 35866178]
  36. Gynecol Oncol. 2015 Feb;136(2):274-7 [PMID: 25740603]
  37. J Minim Invasive Gynecol. 2015 May-Jun;22(4):696-7 [PMID: 25623370]
  38. J Mol Med (Berl). 2020 Aug;98(8):1175-1188 [PMID: 32638047]
  39. Acad Radiol. 2016 Oct;23(10):1290-7 [PMID: 27396800]
  40. J Clin Oncol. 2018 Oct 5;:JCO1800454 [PMID: 30289732]
  41. Taiwan J Obstet Gynecol. 2022 Mar;61(2):402-403 [PMID: 35361413]
  42. Diagn Pathol. 2012 Jul 18;7:85 [PMID: 22809451]
  43. FASEB J. 2008 Feb;22(2):338-42 [PMID: 17884971]
  44. Genes Chromosomes Cancer. 2021 Oct;60(10):713-717 [PMID: 34184333]
  45. J Oral Maxillofac Surg. 2013 Sep;71(9):1626-33 [PMID: 23623197]
  46. Int Cancer Conf J. 2018 Nov 12;8(1):33-38 [PMID: 31149544]
  47. Environ Sci Pollut Res Int. 2023 Apr;30(16):45498-45514 [PMID: 36800084]
  48. Chemosphere. 2022 Jun;297:133932 [PMID: 35149018]
  49. Gynecol Oncol. 2001 Mar;80(3):372-7 [PMID: 11263934]
  50. Animals (Basel). 2021 Jun 17;11(6): [PMID: 34204419]
  51. Geburtshilfe Frauenheilkd. 2015 Feb;75(2):148-164 [PMID: 25797958]
  52. Front Immunol. 2022 Jul 22;13:939433 [PMID: 35935932]
  53. Clin Obstet Gynecol. 2015 Dec;58(4):710-7 [PMID: 26512438]
  54. Lancet Oncol. 2009 Dec;10(12):1188-98 [PMID: 19959075]
  55. Environ Health Perspect. 2000 Oct;108 Suppl 5:779-84 [PMID: 11035982]
  56. Diagn Cytopathol. 2023 Jan;51(1):E21-E24 [PMID: 36082519]
  57. Histopathology. 2017 Jun;70(7):1138-1146 [PMID: 28130839]
  58. Cureus. 2023 May 16;15(5):e39101 [PMID: 37332439]
  59. BMJ Case Rep. 2011 Dec 20;2011: [PMID: 22669996]
  60. Front Public Health. 2023 Jan 30;11:1039782 [PMID: 36794064]
  61. Gynecol Oncol Rep. 2021 Sep 01;37:100852 [PMID: 34522753]
  62. J Clin Oncol. 2008 Mar 10;26(8):1364-70 [PMID: 18323559]
  63. J Minim Invasive Gynecol. 2015 Mar-Apr;22(3):410-4 [PMID: 25460521]
  64. Med Inform Internet Med. 1999 Oct-Dec;24(4):309-15 [PMID: 10674421]
  65. Int J Mol Sci. 2022 Aug 27;23(17): [PMID: 36077127]
  66. Front Immunol. 2022 Apr 14;13:874640 [PMID: 35493488]
  67. Mod Pathol. 2023 Apr;36(4):100084 [PMID: 36788080]
  68. Front Res Metr Anal. 2020 Dec 23;5:607286 [PMID: 33870064]
  69. Periodontol 2000. 2021 Feb;85(1):237-240 [PMID: 33226679]
  70. Pathol Int. 2007 Oct;57(10):681-7 [PMID: 17803657]
  71. Clin Cancer Res. 2022 May 13;28(10):2147-2159 [PMID: 35302600]
  72. J Control Release. 2022 Dec;352:211-241 [PMID: 36270513]
  73. Curr Probl Cardiol. 2022 Dec;47(12):101361 [PMID: 35995242]
  74. J Gastrointest Cancer. 2012 Jun;43(2):361-3 [PMID: 20549388]
  75. BMJ Glob Health. 2022 Jun;7(6): [PMID: 35760436]
  76. Oncologist. 2015 Apr;20(4):433-9 [PMID: 25765878]
  77. Int J Gynaecol Obstet. 2023 Dec;163(3):868-874 [PMID: 37485666]
  78. J Int Med Res. 2020 Oct;48(10):300060520942107 [PMID: 33100084]
  79. Reprod Sci. 2012 Apr;19(4):339-53 [PMID: 22378865]
  80. Discov Oncol. 2023 Jan 13;14(1):5 [PMID: 36639546]
  81. Eur Radiol. 2008 Apr;18(4):723-30 [PMID: 17929022]
  82. Cancers (Basel). 2023 Apr 23;15(9): [PMID: 37173887]
  83. Fertil Steril. 2007 Apr;87(4):725-36 [PMID: 17430732]

Word Cloud

Created with Highcharts 10.0.0uLMSanalysisbibliometricleiomyosarcomaliteratureprovides20yearscoreresearcharticlesuterineratesourcesrelatedstudylast4comprehensive2489averageannualgrowthtopinfluentialLawBackground:UterineraremalignanttumorlowclinicalspecificitypoorprognosisTheremanystudieshoweverstilllackmetrologicalanalysesgeneralizationMethodsmaterials:choseWebScienceWoSmaindatabasedueextensiveinterdisciplinarycoveragespecificallyfocusedensurerelevancepracticalityutilizingWOSdatasetleveragingRpackage"bibliometricversion10"CitespaceperformedalloweduspinpointhotspotscreatevisualrepresentationsresultingretrievalpertinentResults:reviewcoverspastKeyfindingsincludepublication875607%yearlycitationcount1722Core+Zone2contributed1079207reviewsdisplaying98%identifiedjournalsauthorsprevalencepublicationsUnitedStatesdominanceBradford'sLotka'shighlightedauthorproductivityrespectivelyThematicmappingfactorialrevealedclustersincludingetiologydiagnosistreatmentadvancementssurgicalapproachesprominentthemesgemcitabinedocetaxelOverallinsightstrendsfactorsConclusion:thoroughwholeilluminatesfield'sguidingprinciplesalsorevealingsubtlepatternswithinknowledgegainedcontributescurrentdiscussionscientificfieldssolidbasisfuturepathsliteraturesgynecologicmalignancerelavantkeywordstrendtopic

Similar Articles

Cited By